Cited by 154Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.

Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease

Open access

Searcy, James L., Phelps, Jeremiah T., Pancani, Tristano, Kadish, Inga, Popovic, Jelena, Anderson, Katie L., Beckett, Tina L., Murphy, Michael P., Chen, Kuey-Chu, Blalock, Eric M., Landfield, Philip W., Porter, Nada M., Thibault, Olivier·2012·Journal of Alzheimer's Disease

DOI 10.3233/jad-2012-111661PMC PMC3378773

Open this paper in CoChat — free account

Abstract

Thiazolidinediones (TZDs) are agonists at peroxisome proliferator-activated gamma-type (PPAR-γ) receptors and are used clinically for the treatment of type 2 diabetes where they have been shown to reestablish insulin sensitivity, improve lipid profiles, and reduce inflammation. Recent work also suggests that TZDs may be beneficial in Alzheimer's disease (AD), ameliorating cognitive decline early in the disease process. However, there have been only a few studies identifying mechanisms through which cognitive benefits may be exerted. Starting at 10 months of age, the triple transgenic mouse model of AD (3xTg-AD) with accelerated amyloid-β (Aβ) deposition and tau pathology was treated with the TZD pioglitazone (PIO-Actos) at 18 mg/Kg body weight/day. After four months, PIO-treated animals showed multiple beneficial effects, including improved learning on the active avoidance task, reduced serum cholesterol, decreased hippocampal amyloid-β and tau deposits, and enhanced short- and long-term plasticity. Electrophysiological membrane properties and post-treatment blood glucose levels were unchanged by PIO. Gene microarray analyses of hippocampal tissue identified predicted transcriptional responses following TZD treatment as well as potentially novel targets of TZDs, including facilitation of estrogenic processes and decreases in glutamatergic and lipid metabolic/cholesterol dependent processes. Taken together, these results confirm prior animal studies showing that TZDs can ameliorate cognitive deficits associated with AD-related pathology, but also extend these findings by pointing to novel molecular targets in the brain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3233/jad-2012-111661

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citation
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
A Model-Based Background Adjustment for Oligonucleotide Expression Arrays
Wu, Z. J., Irizarry, R. A., Gentleman, R. C., Martínez-Murillo, F., & Spencer, F. A. (2004) · Journal of the American Statistical Association · doi:10.1198/016214504000000683 · Cited by 1,717
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of alzheimer’s disease.
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Deaths: preliminary data for 2003.
Hoyert, D. L., Kung, H.-C., & Smith, B. L. (2005) · PubMed · Cited by 1,649
Memantine for dementia
McShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155
NCBI GEO: archive for high-throughput functional genomic data
Barrett, T., Troup, D. B., Wilhite, S. E., Ledoux, P., Rudnev, D., Evangelista, C., Kim, I. F., Soboleva, A., Tomashevsky, M., Marshall, K. A., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn764 · Cited by 1,043
Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses
Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., & Landfield, P. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308512100 · Cited by 1,025
Self-citation
Central obesity and increased risk of dementia more than three decades later
Whitmer, R. A., Gustafson, D. R., Barrett-Connor, E., Haan, M. N., Gunderson, E. P., & Yaffe, K. (2008) · Neurology · doi:10.1212/01.wnl.0000306313.89165.ef · Cited by 803
The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 731
PPARs: therapeutic targets for metabolic disease
Berger, J. P., Akiyama, T. E., & Meinke, P. T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.003 · Cited by 716
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Cognition and diabetes: a lifespan perspective
Biessels, G. J., Deary, I. J., & Ryan, C. M. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70021-8 · Cited by 662
Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy
Minkeviciene, R., Rheims, S., Dobszay, M. B., Zilberter, M. Y., Hartikainen, J., Fülöp, L., Penke, B., Zilberter, Y., Harkany, T., Pitkänen, A., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5215-08.2009 · Cited by 648
Nuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. H. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 647
Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone
Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 614
Gene Microarrays in Hippocampal Aging: Statistical Profiling Identifies Novel Processes Correlated with Cognitive Impairment
Blalock, E. M., Chen, K.-C., Sharrow, K., Herman, J. P., Porter, N. M., Foster, T. C., & Landfield, P. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03807.2003 · Cited by 570
Self-citation
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice
Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F., & Landreth, G. E. (2005) · Brain · doi:10.1093/brain/awh452 · Cited by 565
A Behavioral Role for Dendritic Integration
Nolan, M. F., Malleret, G., Dudman, J. T., Buhl, D. L., Santoro, B., Gibbs, E., Vronskaya, S., Buzsáki, G., Siegelbaum, S. A., Kandel, E. R., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.020 · Cited by 487
Anti-Inflammatory Drug Therapy Alters β-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease
Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., & Landreth, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07504.2003 · Cited by 469
Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults
Lipton, S. A. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.1.101 · Cited by 423
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
Danysz, W., & Parsons, C. G. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.938 · Cited by 404
The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications
Brinton, R. D. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.003 · Cited by 396
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Sato, T., Hanyu, H., Hirao, K., Kanetaka, H., Sakurai, H., & Iwamoto, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.009 · Cited by 387
Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ
Sastre, M., Dewachter, I., Rossner, S., Bogdanovic, N., Rosen, E., Borghgraef, P., Evert, B. O., Dumitrescu-Ozimek, L., Thal, D. R., Landreth, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503839103 · Cited by 373
Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
Carroll, J. C., Rosario, E. R., Chang, L., Stanczyk, F. Z., Oddo, S., LaFerla, F. M., & Pike, C. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2718-07.2007 · Cited by 369
Effects of Pioglitazone on Adipose Tissue Remodeling Within the Setting of Obesity and Insulin Resistance
de Souza, C. J., Eckhardt, M., Gagen, K., Dong, M., Chen, W., Laurent, D., & Burkey, B. F. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1863 · Cited by 351
Enhanced Ryanodine Receptor Recruitment Contributes to Ca2+Disruptions in Young, Adult, and Aged Alzheimer's Disease Mice
Stutzmann, G. E., Smith, I. F., Caccamo, A., Oddo, S., LaFerla, F. M., & Parker, I. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0739-06.2006 · Cited by 327
Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling
Abdul, H. M., Sama, M. A., Furman, J. L., Mathis, D. M., Beckett, T. L., Weidner, A. M., Patel, E., Baig, I., Murphy, M. P., LeVine, H., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1064-09.2009 · Cited by 324
Self-citation
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Pedersen, W. A., McMillan, P. J., Kulstad, J. J., Leverenz, J. B., Craft, S., & Haynatzki, G. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.018 · Cited by 320
Olfactory Dysfunction Correlates with Amyloid-β Burden in an Alzheimer's Disease Mouse Model
Wesson, D. W., Levy, E., Nixon, R. A., & Wilson, D. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4622-09.2010 · Cited by 290
Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes
Ryan, C. M., Freed, M. I., Rood, J. A., Cobitz, A. R., Waterhouse, B. R., & Strachan, M. W. J. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1626 · Cited by 289
Deaths: preliminary data for 2009.
Kochanek, K. D., Xu, J., Murphy, S. L., Miniño, A., & Kung, H.-C. (2011) · PubMed · Cited by 282
Elevated Postsynaptic [Ca2+]iand L-Type Calcium Channel Activity in Aged Hippocampal Neurons: Relationship to Impaired Synaptic Plasticity
Thibault, O., Hadley, R. W., & Landfield, P. W. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09744.2001 · Cited by 279
Self-citation
Pathologically activated therapeutics for neuroprotection
Lipton, S. A. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2229 · Cited by 268
Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist
Nicolakakis, N., Aboulkassim, T., Ongali, B., Lecrux, C., Fernandes, P., Rosa-Neto, P., Tong, X.-K., & Hamel, E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3348-08.2008 · Cited by 262
17β-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: A potential initiation mechanism for estrogen-induced neuroprotection
Wu, T.-W., Wang, J.-M., Chen, S.-H., & Brinton, R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.027 · Cited by 249
Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease?
Sparks, D. L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48466.x · Cited by 244
Rosiglitazone rescues memory impairment in Alzheimer’s transgenic mice: Mechanisms involving a reduced amyloid and tau pathology
Escribano, L., Simón, A.-M., Gimeno, E., Cuadrado-Tejedor, M., López de Maturana, R., García-Osta, A., Ricobaraza, A., Pérez-Mediavilla, A., Del Río, J., & Frechilla, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.32 · Cited by 235
Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging
Foster, T. C. (2012) · Hippocampus · doi:10.1002/hipo.20935 · Cited by 231
Characterization of the 3xTg-AD mouse model of Alzheimer’s disease: Part 2. Behavioral and cognitive changes
Sterniczuk, R., Antle, M. C., LaFerla, F. M., & Dyck, R. H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.011 · Cited by 228
Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice
Martínez‐Coria, H., Green, K. N., Billings, L. M., Kitazawa, M., Albrecht, M., Rammes, G., Parsons, C. G., Gupta, S., Banerjee, P., & LaFerla, F. M. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090452 · Cited by 224
Hippocampal Expression Analyses Reveal Selective Association of Immediate-Early, Neuroenergetic, and Myelinogenic Pathways with Cognitive Impairment in Aged Rats
Rowe, W. B., Blalock, E. M., Chen, K.-C., Kadish, I., Wang, D., Barrett, J. E., Thibault, O., Porter, N. M., Rose, G. M., & Landfield, P. W. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4163-06.2007 · Cited by 215
Self-citation
Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes
Howlett, D. R., Richardson, J. C., Austin, A., Parsons, A. A., Bate, S. T., Davies, D. C., & Gonzalez, M. I. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.029 · Cited by 212
Quality Assessment of Affymetrix GeneChip Data
Bolstad, B. M., Collin, F., Brettschneider, J. A., Simpson, K., Cope, L., Irizarry, R. A., & Speed, T. P. (2005) · Springer eBooks · doi:10.1007/0-387-29362-0_3 · Cited by 197
The Effect of Pioglitazone on Peroxisome Proliferator-Activated Receptor-γ Target Genes Related to Lipid Storage In Vivo
Bogacka, I., Xie, H., Bray, G. A., & Smith, S. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1660 · Cited by 197
A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Reisberg, ‌., Doody, R. S., Stöffler, A., Schmitt, F. A., Ferris, S. H., & Möbius, H. J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.49 · Cited by 183
Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised
Lacombe, P., Mathews, P. M., Schmidt, S., Breidert, T., Heneka, M., Landreth, G., Feinstein, D. L., & Galea, E. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-11 · Cited by 179
DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice
Arsenault, D., Julien, C., Tremblay, C., & Calon, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017397 · Cited by 177
Early and Simultaneous Emergence of Multiple Hippocampal Biomarkers of Aging Is Mediated by Ca2+-Induced Ca2+Release
Gant, J. C., Sama, M. M., Landfield, P. W., & Thibault, O. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4171-05.2006 · Cited by 176
Self-citation
Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease
Luchsinger, J. A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.048 · Cited by 171
Peroxisome Proliferator-Activated Receptor γ Induces a Clearance Mechanism for the Amyloid-β Peptide
Espuny-Camacho, I., Serneels, L., Spittaels, K., Merchiers, P., Dominguez, D. I., & Strooper, B. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3987-04.2004 · Cited by 171
Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease
Landreth, G. E. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00296-2 · Cited by 169
Hippocampal and Cognitive Aging across the Lifespan: A Bioenergetic Shift Precedes and Increased Cholesterol Trafficking Parallels Memory Impairment
Kadish, I., Thibault, O., Blalock, E. M., Chen, K.-C., Gant, J. C., Porter, N. M., & Landfield, P. W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4599-08.2009 · Cited by 155
Self-citation
Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats
Dias, C. P., de Lima, M. N. M., Presti-Torres, J., Dornelles, A. D. S., Garcia, V. A., Scalco, F. S., Guimarães, M. R., Constantino, L. D. S., Budni, P., Dal‐Pizzol, F., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.018 · Cited by 146
11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory
Seckl, J. R., & Walker, B. R. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.09.007 · Cited by 138
Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer’s disease mouse model
Escribano, L., Simón, A., Pérez‐Mediavilla, A., Colocho, P. E. S., Río, J. D., & Frechilla, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.071 · Cited by 135
Deletion of the Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Auxiliary Subunit TRIP8b Impairs HippocampalIhLocalization and Function and Promotes Antidepressant Behavior in Mice
Lewis, A. S., Vaidya, S. P., Blaiss, C. A., Liu, Z., Stoub, T. R., Brager, D. H., Chen, X., Bender, R. A., Estep, C. M., Popov, A. B., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0936-11.2011 · Cited by 129
Alterations in intrinsic neuronal excitability during normal aging
Disterhoft, J. F., & Oh, M. M. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00297.x · Cited by 128
Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease
Alexandrov, P. N., Pogue, A., Bhattacharjee, S., & Lukiw, W. J. (2011) · Neuroreport · doi:10.1097/wnr.0b013e3283497334 · Cited by 128
17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: Relevance to Alzheimer's prevention
Zhao, L., Yao, J., Mao, Z., Chen, S., Wang, Y., & Brinton, R. D. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.010 · Cited by 124
Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease
Chou, J. L., Shenoy, D. V., Thomas, N., Choudhary, P. K., LaFerla, F. M., Goodman, S. R., & Breen, G. A. M. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2010.12.012 · Cited by 123
Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Agonists for Neurological Disease
Feinstein, D. L. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503763816481 · Cited by 116
The effects of cholesterol on learning and memory
Schreurs, B. G. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.04.010 · Cited by 114
iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease
Martin, B., Brenneman, R., Becker, K. G., Guček, M., Cole, R. N., & Maudsley, S. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002750 · Cited by 113
Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity
Kemp, D. E., Ismail-Beigi, F., Ganocy, S. J., Conroy, C., Gao, K., Obral, S., Fein, E., Findling, R. L., & Calabrese, J. R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.033 · Cited by 109
Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats
García‐Bueno, B., Madrigal, J. L. M., Lizasoaín, I., Moro, M. Á., Lorenzo, P. L., & Leza, J. C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.007 · Cited by 108
Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease
PEDERSEN, W., & FLYNN, E. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.003 · Cited by 108
Lipin 1 Represses NFATc4 Transcriptional Activity in Adipocytes To Inhibit Secretion of Inflammatory Factors
Kim, H. B., Kumar, A. T., Wang, L., Liu, G., Keller, S. R., Lawrence, J. C., Finck, B. N., & Harris, T. E. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01671-09 · Cited by 108
Modulation of NMDA Receptor Properties and Synaptic Transmission by the NR3A Subunit in Mouse Hippocampal and Cerebrocortical Neurons
Tong, G., Takahashi, H., Tu, S., Shin, Y., Talantova, M. V., Zago, W. M., Xia, P., Nie, Z., Goetz, T., Zhang, D., et al. (2007) · Journal of Neurophysiology · doi:10.1152/jn.01044.2006 · Cited by 98
Cholesterol, Aβ and Alzheimer's disease
Hartmann, T. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01990-1 · Cited by 98
Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL/6 mice
Mielke, J. G., Nicolitch, K., Avellaneda, V., Earlam, K., Ahuja, T. K., Mealing, G. A. R., & Messier, C. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.09.010 · Cited by 97
Rosiglitazone and Cognitive Stability in Older Individuals With Type 2 Diabetes and Mild Cognitive Impairment
Abbatecola, A. M., Lattanzio, F., Molinari, A. M., Cioffi, M., Mansi, L., Rambaldi, P., DiCioccio, L., Cacciapuoti, F., Canonico, R., & Paolisso, G. (2010) · Diabetes Care · doi:10.2337/dc09-2030 · Cited by 93
Novel glutamatergic agents for major depressive disorder and bipolar disorder
Machado-Vieira, R., Ibrahim, L., Henter, I. D., & Zarate, C. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.010 · Cited by 92
Correlation Between Aβx-40–, Aβx-42–, and Aβx-43–Containing Amyloid Plaques and Cognitive Decline
Parvathy, S., Davies, P., Haroutunian, V. H., Purohit, D. P., Davis, K. L., Mohs, R. C., Park, H., Moran, T. M., Chan, J. Y., & Buxbaum, J. D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.2025 · Cited by 90
Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status
Rodriguez-Rivera, J., Denner, L. A., & Dineley, K. T. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.002 · Cited by 88
Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain
Loane, D. J., Deighan, B. F., Clarke, R. M., Griffin, R. J., Lynch, A. M., & Lynch, M. A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.09.001 · Cited by 87
17β-Estradiol Benzoate Decreases the AHP Amplitude in CA1 Pyramidal Neurons
Kumar, A., & Foster, T. C. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.2.621 · Cited by 87
Estrogen and Hippocampal Plasticity in Rodent Models
Foy, M., Baudry, M., Brinton, R., & Thompson, R. F. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15406 · Cited by 81
More than a decade of estrogen neuroprotection
Simpkins, J. W., & Singh, M. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.10.009 · Cited by 75
Distinct modulation of voltage‐gated and ligand‐gated Ca2+ currents by PPAR‐γ agonists in cultured hippocampal neurons
Pancani, T., Phelps, J. T., Searcy, J. L., Kilgore, M. W., Chen, K.-C., Porter, N. M., & Thibault, O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06107.x · Cited by 75
Self-citation
Aberrant Detergent-Insoluble Excitatory Amino Acid Transporter 2 Accumulates in Alzheimer Disease
Woltjer, R. L., Duerson, K. C., Fullmer, J. M., Mookherjee, P., Ryan, A. M., Montine, T. J., Kaye, J. A., Quinn, J. F., Silbert, L. C., Erten‐Lyons, D., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e24adb · Cited by 73
Relation of Improvement in Endothelium-Dependent Flow-Mediated Vasodilation After Rosiglitazone to Changes in Asymmetric Dimethylarginine, Endothelin-1, and C-Reactive Protein in Nondiabetic Patients With the Metabolic Syndrome
Wang, T., Chen, W., Cheng, W., Lin, J., Chen, M.-F., & Lee, Y. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.05.027 · Cited by 72
Anticonvulsant potential of the peroxisome proliferator-activated receptor gamma agonist pioglitazone in pentylenetetrazole-induced acute seizures and kindling in mice
Abdallah, D. M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.034 · Cited by 67
Remembrance of Arguments Past: How Well Is the Glutamate Receptor Hypothesis of LTP Holding Up after 20 Years?
Baudry, M., & LYNCH, G. S. (2001) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2001.4023 · Cited by 64
The Early and Ongoing Experience with the Cholesterol-Fed Rabbit as a Model of Alzheimer's Disease: The Old, the New and the Pilot
Sparks, D. L. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15410 · Cited by 62
11β-Hydroxysteroid Dehydrogenase Type 1 Deficiency Prevents Memory Deficits with Aging by Switching from Glucocorticoid Receptor to Mineralocorticoid Receptor-Mediated Cognitive Control
Yau, J. L. W., Noble, J., & Seckl, J. R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6145-10.2011 · Cited by 59
To Gate or not to Gate: Are the Delta Subunits in the Glutamate Receptor Family Functional Ion Channels?
Schmid, S. M., & Hollmann, M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8025-0 · Cited by 55
Changes in Apolipoprotein E Expression in Response to Dietary and Pharmacological Modulation of Cholesterol
Petanceska, S. S., DeRosa, S., Sharma, A., Diaz, N. S., Duff, K., Tint, S. G., Refolo, L. M., & Pappolla, M. A. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:395 · Cited by 52
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
Effects of Long-Term Pioglitazone Treatment on Peripheral and Central Markers of Aging
Blalock, E. M., Phelps, J. T., Pancani, T., Searcy, J. L., Anderson, K. L., Gant, J. C., Popović, J., Avdiushko, M. G., Cohen, D. A., Chen, K.-C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010405 · Cited by 51
Self-citation
Troglitazone, a peroxisome proliferator‐activated receptor‐γ agonist, decreases tau phosphorylation in CHOtau4R cells
d’Abramo, C., Ricciarelli, R., Pronzato, M. A., & Davies, P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03931.x · Cited by 45
Role of Protein Phosphatases in Estrogen-Mediated Neuroprotection
Yi, K. D., Chung, J., Pang, P. S., & Simpkins, J. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1328-05.2005 · Cited by 42
Estradiol Reverses a Calcium-Related Biomarker of Brain Aging in Female Rats
Brewer, L. D., Dowling, A., Curran-Rauhut, M., Landfield, P., Porter, N., & Blalock, E. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5253-08.2009 · Cited by 41
Self-citation
Olfactory and Visuospatial Learning and Memory Performance in Two Strains of Alzheimer's Disease Model Mice—A Longitudinal Study
Phillips, M. E., Boman, E. M., Österman, H., Willhite, D. C., & Laska, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019567 · Cited by 41
Combination Therapy of Rosiglitazone, a Peroxisome Proliferator‐Activated Receptor‐γ Ligand, and NMDA Receptor Antagonist (MK‐801) on Experimental Embolic Stroke in Rats
Allahtavakoli, M., Shabanzadeh, A. P., Roohbakhsh, A., & Pourshanazari, A. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00127.x · Cited by 40
Action potential throughput in aged rat hippocampal neurons: Regulation by selective forms of hyperpolarization
Gant, J. C., & Thibault, O. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.006 · Cited by 37
Self-citation
The ε3 and ε4 Alleles of Human APOE Differentially Affect Tau Phosphorylation in Hyperinsulinemic and Pioglitazone Treated Mice
To, A. W. M., Ribé, E. M., Chuang, T. T., Schroeder, J. E., & Lovestone, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016991 · Cited by 37
Agonists of peroxisome proliferator-activated receptor-γ attenuate the Aβ-mediated impairment of LTP in the hippocampus in vitro
Costello, D. A., O’Leary, D. M., & Herron, C. E. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.009 · Cited by 36
Glutamate receptor-mediated restoration of experience-dependent place field expansion plasticity in aged rats.
Burke, S. N., Maurer, A. P., Yang, Z., Navratilova, Z., & Barnes, C. A. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.3.535 · Cited by 36
Differential effects of NMDA–receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices
Frankiewicz, T., Pilc, A., & Parsons, C. G. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00168-9 · Cited by 35
Ameliorative effect of pioglitazone on seizure responses in genetically epilepsy-susceptible EL mice
Okada, K., Yamashita, U., & Tsuji, S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.108 · Cited by 34
Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines
Pop, V., Head, E., Berchtold, N. C., Glabe, C. G., Studzinski, C. M., Weidner, A. M., Murphy, M. P., & Cotman, C. W. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.008 · Cited by 31
Self-citation
Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors
Messier, C., & Gagnon, M. (2009) · Diabetologia · doi:10.1007/s00125-009-1533-2 · Cited by 28
Spatial discrimination, reversal and active or passive avoidance learning in rats with ka-induced neuronal depletions in dorsal hippocampus
Muñoz, C., & Grossman, S. P. (1981) · Brain Research Bulletin · doi:10.1016/s0361-9230(81)80010-x · Cited by 27
Effects of nonsteroidal anti-inflammatory drugs on amyloid-β pathology in mouse skeletal muscle
Beckett, T. L., Niedowicz, D. M., Studzinski, C. M., Weidner, A. M., Webb, R. L., Holler, C. J., Ahmed, R. R., LeVine, H., & Murphy, M. P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.018 · Cited by 21
Self-citation
A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats
Henriksen, K., Byrjalsen, I., Nielsen, R. H., Madsen, A. N., Larsen, L. K., Christiansen, C., Beck‐Nielsen, H., & Karsdal, M. A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.051 · Cited by 19
Transgenic AD Model Mice, Effects of Potential Anti-AD Treatments on Inflammation, and Pathology
van Groen, T., Miettinen, P., & Kadish, I. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101479 · Cited by 18
Self-citation
Rosiglitazone Cools Down Inflammation in the Metabolic Syndrome
Esposito, K., Ciotola, M., Merante, D., & Giugliano, D. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000223874.94624.11 · Cited by 15
Lipophilicity as a determinant of thiazolidinedione action in vitro: findings from BLX-1002, a novel compound without affinity to PPARs
Brunmair, B., Staniek, K., Lehner, Z., Dey, D., Bolten, C. W., Stadlbauer, K., Luger, A., & Fürnsinn, C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00401.2010 · Cited by 6

Flagged first, then by citations

Research works printed but not linked: 1

[59]Gant JC Thibault O Action potential throughput in aged rat hippocampal neurons: Regulation by selective forms of hyperpolarization Neurobiol Aging 2008 30 2053 2064 18367293 PMC2776637

Sorted by citations

Mitochondrial Diseases of the Brain
Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 426
Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402
Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions
Andrieu, S., Coley, N., Lovestone, S., Aisen, P. S., & Vellas, B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00153-2 · Cited by 293
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00118 · Cited by 227
Alzheimer’s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions
Jayaraman, A., & Pike, C. J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0476-2 · Cited by 185

See all 154

Authors: Searcy, J. L., Phelps, J. T., Pancani, T., Kadish, I., Popovic, J., Anderson, K. L., Beckett, T. L., Murphy, M. P., Chen, K.-C., Blalock, E. M., Landfield, P. W., Porter, N. M., & Thibault, O.
Affiliations: University of Kentucky (US)
University of Alabama at Birmingham (US)
Department of Molecular and Biomedical Pharmacology, University of Kentucky Medical Center, Lexington, KY, USA
Corresponding author: Thibault, Olivier
ORCID: Anderson, Katie L.
Blalock, Eric M.
Thibault, Olivier
Venue: Journal of Alzheimer's Disease
Publisher: SAGE Publications
Published: 2012-06-18
Volume: 30
Issue: 4
Pages: 943-961
ISSN: 1387-2877 (ISSN-L)
1875-8908
DOI: 10.3233/jad-2012-111661
PMC: PMC3378773
OpenAlex: W1554596985
Cited by: 154
References: 113
Citations by year: 2026: 5 · 2025: 6 · 2024: 8 · 2023: 6 · 2022: 8 · 2021: 17 · 2020: 11 · 2019: 9 · 2018: 10 · 2017: 13 · 2016: 14 · 2015: 18 · 2014: 16 · 2013: 10 · 2012: 3
FWCI: 10.08
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Journal of Alzheimer s Disease (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: University of California, Irvine
National Institute on Aging (AG-029268, R21AG029268, P01AG010836, AG033649, AG020251, R01AG020251, AG010836, R01AG034605, AG034605, R01AG033649, R01AG037868)
National Center for Research Resources (P20RR015592, P20RR15592)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: pioglitazone, thiazolidinediones
MeSH terms: Pioglitazone, Alzheimer Disease, Animals, Brain Chemistry, Disease Models, Animal, Drug Administration Schedule, Female, Learning, Mice, Transgenic, Time Factors, Biomarkers, Thiazolidinediones, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks